EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FREQUENCY OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

Abdullah, Fazal Ur Rehman, Rahat Shah, Alexander Arshad, Sanaullah Kakar, Aimal Khan

Journal of Medical & Health Sciences Review · 29.12.2025 · 2 (4) · 87-95

DOI: 10.65035/jkxn4263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical & Health Sciences Review, online erschienen am 29.12.2025. Verfasst von Abdullah und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Percutaneous coronary intervention (PCI) is associated with an established risk of developing contrast-induced nephropathy (CIN), which is associated with greater morbidity, longer hospital stay, and poor cardiovascular outcomes. To prevent renal failure after contrast dye, it is important to identify patients at risk.

Objective

To investigate the prevalence of contrast-induced nephropathy in patients with PCI and to evaluate the relationship between contrast-induced nephropathy and certain clinical risk factors. Place and duration of study. From May 2025 to October 2025, Cardiology Department Bolan Medical College / Hospital Quetta/ Sandeman Provincial Hospital, Quetta. Methodology: This cross-sectional study was carried out in the Department of Cardiology at a tertiary care hospital for 6 months. One hundred patients undergoing elective or emergency PCI were consecutively sampled. The serum creatinine was measured at baseline before PCI and again 48-72 hours after contrast administration. CIN was defined as a rise in the level of serum creatinine by ≥0.5 mg/dL or ≥25% from baseline. Demographic and clinical parameters were documented and analyzed using SPSS v26. A p-value of ≤ 0.05 was set as significant.

Results

The study included 100 patients with a mean age of 58.4±10.7 years; 68% were male. Diabetes mellitus, hypertension, and pre-existing chronic kidney disease were present in 41%, 57%, and 12% of patients, respectively. Contrast-induced nephropathy developed in 14 (14%) patients. The incidence of CIN was significantly higher among patients aged ≥60 years (p=0.041), those with diabetes mellitus (p=0.048), and those with baseline renal impairment (p=0.029). No significant association was observed between gender and CIN development (p=0.412). Patients who developed CIN had significantly higher post-procedural serum creatinine levels than those without CIN (p

Zitieren

APA

Abdullah, Rehman, F. U., Shah, R., Arshad, A., Kakar, S., & Khan, A. (2025). FREQUENCY OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. Journal of Medical & Health Sciences Review, 2(4), 87-95. https://doi.org/10.65035/jkxn4263

Vancouver

Abdullah, Rehman FU, Shah R, Arshad A, Kakar S, Khan A. FREQUENCY OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. Journal of Medical & Health Sciences Review. 2025;2(4):87-95. doi:10.65035/jkxn4263

BibTeX
@article{Abdullah2025,
  author = {Abdullah and Rehman, Fazal Ur and Shah, Rahat and Arshad, Alexander and Kakar, Sanaullah and Khan, Aimal},
  title = {FREQUENCY OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION},
  journal = {Journal of Medical & Health Sciences Review},
  year = {2025},
  volume = {2},
  number = {4},
  pages = {87--95},
  doi = {10.65035/jkxn4263}
}
Kostenlos starten →